All In Biotech

Drug Trial Radar · NCT00107952

Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus

A Phase 3, Randomized, Double-Blind, Parallel-Group, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Hospital-Acquired Pneumonia With a Focus on Patients With Infections Due to Methicillin-Resistant Staphylococcus Aureus

Last checked: Nov 20, 2026Latest source record: Jan 16, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 761 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

761

Actual

Start

Feb 2005

Primary completion

Jul 2007

Study completion Jul 2007

Sponsor

Lead sponsor
Cumberland PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Apr 12, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study 0015 (NCT00107952) compares the safety and effectiveness of an investigational drug, telavancin, with vancomycin for the treatment of hospital-acquired pneumonia.

Conditions

  • Bacterial Pneumonia

Interventions

  • TelavancinDrug

    Telavancin 10 mg/kg/day IV for up to 21 days.

  • VancomycinDrug

    Vancomycin 1 Gm IV q 12 hrs for up to 21 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical ResponseTime frame: 7 - 14 days following end of antibiotic treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Baystate Medical Center

    Springfield, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.